✦ LIBER ✦

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

✍ Scribed by John Schindler; Srikanth Gajavelli; Farhad Ravandi; YuMin Shen; Samir Parekh; Ira Braunchweig; Stefan Barta; Victor Ghetie; Ellen Vitetta; Amit Verma

Book ID: 108677339
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 134 KB
Volume: 154
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08762.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergy of sequential administration of

Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia

✍ Barta, Stefan K.; Zou, Yiyu; Schindler, John; Shenoy, Niraj; Bhagat, Tushar D.; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 280 KB

930 A clinical phase I study of an anti-

930 A clinical phase I study of an anti-CD25-deglycosylated ricin A-chain immunotoxin (RFT5-SMPT-DGA) in patients with refractory Hodgkin's disease

✍ R. Schnell; M.-T. Hatwig; A. Radszuhn; F. Cebe; S. Drillich; G. Schön; H. Bohlen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A phase I study of PRO131921, a novel an

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics

✍ Casulo, Carla; Vose, Julie M.; Ho, William Y.; Kahl, Brad; Brunvand, Mark; Goy, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Lineage specific treatment of adult pati

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine : Cancer and Leukemia Group B Study 9311

✍ Ted P. Szatrowski; Richard K. Dodge; Carol Reynolds; Carol A. Westbrook; Stanley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Background: Anti-b4-blocked ricin is an immunotoxin comprised of an anti-cd19 murine monoclonal antibody (b4) conjugated to blocked ricin, which has cytotoxic activity in patients with lymphoid malignancies. ## Methods: Adults with untreated acute lymphoblastic leukemia (all) were treated with

A phase I and pharmacodynamic study of s

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB

A Phase I Study of CPX-351 in Combinatio

A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia

✍ Gergis, Usama; Roboz, Gail; Shore, Tsiporah; Ritchie, Ellen; Mayer, Sebastian; W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB